Obesity Preclinical Contract Research Solutions

Online Inquiry

First Name *

Last Name *

Business Email *

Phone

Company/Institution

Job Title

Services of Interest *

When do you expect your project to start?

Project Description

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Safety-Focused Preclinical Services for Obesity

Inquiry

At Ace Therapeutics, we recognize the complexities of developing novel therapies for obesity—a multifactorial metabolic disorder with growing global health implications. Our preclinical contract research organization specializes in mechanistic assessments designed to uncover safety liabilities early, enabling informed decision-making for obesity-focused drug candidates. By integrating advanced experimental models with hypothesis-driven study designs, we empower sponsors to prioritize compounds with optimized benefit-risk profiles.

Why Mechanistic Safety Evaluations Matter in Obesity Research

Identifying potential adverse effects and establishing safe dosage ranges are crucial in the preclinical phase. Thorough safety evaluations can prevent costly delays or termination of drug candidates. However, preclinical safety assessment for obesity drugs faces challenges due to the heterogeneity of the condition and the limitations of animal models. Understanding how a drug works at a molecular and cellular level is essential for predicting its efficacy and potential off-target effects. Mechanistic studies inform critical decisions in drug development, potentially saving time and resources. These studies utilize in vitro assays, in vivo models, and advanced analytical endpoints. Challenges exist due to the limitations of animal models in fully replicating human physiology.

Core Service Modules for Obesity-Focused Programs

Ace Therapeutics offers a comprehensive suite of preclinical services for obesity, with a strong emphasis on both safety and mechanism of action assessments.

Safety Evaluation

Acute, Sub-chronic, Chronic Toxicology Studies
Safety Pharmacology Studies

Pharmacokinetics & Pharmacodynamics

ADME profiling
Dose-response studies
Target engagement assays

Mechanism of Action Studies

In vitro assays
In vivo efficacy studies
Biomarker analysis
Metabolic profiling
Whole-brain imaging

Animal Models

Diet-Induced Obesity (DIO) models
Genetic Obesity Models (e.g., ob/ob, db/db mice)
Custom models available

Analytical Endpoints

Body composition analysis (e.g., echoMRI)
Energy expenditure measurements (e.g., indirect calorimetry)
Food intake monitoring
Glucose tolerance tests
Insulin tolerance tests
Lipid profiling
Histology
Biomarker analysis

Why Choose Ace Therapeutics for Your Preclinical Obesity Research?

Specialized Expertise: Focused knowledge in preclinical obesity research.
Rigorous Scientific Standards: Ensuring high-quality, reproducible data for regulatory submissions.
Tailored Approach: Customized study designs to meet your specific research needs.
Faster Timelines & Cost-Effective Solutions: Efficient study management practices.
Holistic Preclinical Assessment: Emphasis on both safety and mechanism of action for comprehensive drug evaluation.
Cutting-Edge Methodologies: Utilizing the latest advancements in obesity research.

Partner with Ace Therapeutics to leverage our expertise in safety-focused mechanistic assessments and accelerate the preclinical development of your novel obesity therapeutics. Contact us today to discuss your specific research needs and discover how our dedicated team can provide expert guidance and support throughout the critical preclinical phase.